Status:
COMPLETED
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.
Lead Sponsor:
Pfizer
Conditions:
Neuralgia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To evaluate long-term safety and efficacy of pregabalin in patients with postherpetic neuralgia.
Eligibility Criteria
Inclusion
- Must have met the inclusion criteria for preceding double-blind BID study in postherpetic neuralgia
- Must have received pregabalin/placebo under double-blind conditions for a minimum of 3 weeks.
Exclusion
- Patients cannot participate if they experienced a serious adverse event during preceding double-blind BID study which was determined to be related to the study medication.
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
276 Patients enrolled
Trial Details
Trial ID
NCT00150436
Start Date
February 1 2002
End Date
July 1 2005
Last Update
December 22 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.